IDEX Q3 diluted EPS rises 15% to $1.95
Bitget2026/10/28 11:24- IDEX’s third-quarter 2026 diluted EPS rose 15% year over year to $1.95, primarily due to improved operational results.
- Net sales increased 8% to $951.7 million, driven by higher volumes, primarily in Health & Science Technologies, and positive pricing.
- Orders climbed 13% to $991.2 million, while operating cash flow rose 18% to $239.5 million.
- Chief Executive Eric D. Ashleman said momentum was broadening across the portfolio beyond advantaged markets and larger acquired businesses.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
Crypto prices
More
